Search research articles
Contact Us
Filters
Showing results (1-10 of 46) with videos related to
Page
of 5
Sort By:
Leukemia
|
July 1, 1996
MDR1 reversal: criteria for clinical trials designed to overcome the multidrug resistance phenotype
S Hegewisch-Becker
MMW Fortschritte Der Medizin
|
July 27, 2001
[Addition of hyperthermia. Heat potentiates cancer therapy]
S Hegewisch-Becker, D K Hossfeld
Annals of Hematology
|
March 1, 1996
The MDR phenotype in hematologic malignancies: prognostic relevance and future perspectives
S Hegewisch-Becker, D K Hossfeld
Haematology and Blood Transfusion
|
January 1, 1990
Colony-stimulating factors (rhG-CSF, rhGM-CSF, rhIL-3, and BCGF) recruit myeloblastic and lymphoblastic leukemic cells and enhance the cytotoxic effects of cytosine-arabinoside
M Andreeff, A Tafuri, S Hegewisch-Becker
Deutsche Medizinische Wochenschrift (1946)
|
September 26, 2003
[Hyperthermia: current status and therapeutic results]
P Wust, S Hegewisch-Becker, R Issels
American Journal of Hematology
|
June 27, 2003
Pleural effusion of a second neoplasm in a patient with B-CLL: two immunological compartments
D Atanackovic, S Brettner, S Hegewisch-Becker
European Journal of Haematology
|
January 1, 1996
Prolongation of medium exchange is associated with a decrease in function but not expression of the P-glycoprotein pump in leukaemic cells
S Hegewisch-Becker, C Faltz, D K Hossfeld
Deutsche Medizinische Wochenschrift (1946)
|
October 19, 2001
[New indications for thalidomide?]
G Tuinmann, S Hegewisch-Becker, D K Hossfeld
British Journal of Haematology
|
September 1, 1993
Exposure to lipophilic industrial solvents leads to increased P-glycoprotein expression in peripheral blood cells
S Hegewisch-Becker, A Szudra, D K Hossfeld
Deutsche Medizinische Wochenschrift (1946)
|
May 9, 2000
[Laparoscopic splenectomy for idiopathic thrombocytopenia]
C Zornig, A Emmermann, S Hegewisch-Becker, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 46) with videos related to
Sort By:
Page
of 5
Leukemia
|
July 1, 1996
MDR1 reversal: criteria for clinical trials designed to overcome the multidrug resistance phenotype
S Hegewisch-Becker
MMW Fortschritte Der Medizin
|
July 27, 2001
[Addition of hyperthermia. Heat potentiates cancer therapy]
S Hegewisch-Becker, D K Hossfeld
Annals of Hematology
|
March 1, 1996
The MDR phenotype in hematologic malignancies: prognostic relevance and future perspectives
S Hegewisch-Becker, D K Hossfeld
Haematology and Blood Transfusion
|
January 1, 1990
Colony-stimulating factors (rhG-CSF, rhGM-CSF, rhIL-3, and BCGF) recruit myeloblastic and lymphoblastic leukemic cells and enhance the cytotoxic effects of cytosine-arabinoside
M Andreeff, A Tafuri, S Hegewisch-Becker
Deutsche Medizinische Wochenschrift (1946)
|
September 26, 2003
[Hyperthermia: current status and therapeutic results]
P Wust, S Hegewisch-Becker, R Issels
American Journal of Hematology
|
June 27, 2003
Pleural effusion of a second neoplasm in a patient with B-CLL: two immunological compartments
D Atanackovic, S Brettner, S Hegewisch-Becker
European Journal of Haematology
|
January 1, 1996
Prolongation of medium exchange is associated with a decrease in function but not expression of the P-glycoprotein pump in leukaemic cells
S Hegewisch-Becker, C Faltz, D K Hossfeld
Deutsche Medizinische Wochenschrift (1946)
|
October 19, 2001
[New indications for thalidomide?]
G Tuinmann, S Hegewisch-Becker, D K Hossfeld
British Journal of Haematology
|
September 1, 1993
Exposure to lipophilic industrial solvents leads to increased P-glycoprotein expression in peripheral blood cells
S Hegewisch-Becker, A Szudra, D K Hossfeld
Deutsche Medizinische Wochenschrift (1946)
|
May 9, 2000
[Laparoscopic splenectomy for idiopathic thrombocytopenia]
C Zornig, A Emmermann, S Hegewisch-Becker, et al.
Page
of 5